71
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Chemical Composition and Cytotoxicity Evaluation of Lippia origanoides Kunth (Verbenaceae) Leaves Essential Oil on Human Gingival Fibroblasts

, , , , , , ORCID Icon, , & show all
Pages 704-713 | Received 14 Nov 2020, Accepted 11 Aug 2021, Published online: 09 Sep 2021
 

Abstract

The present study analyzed the chemical composition and evaluated the in vitro cytotoxicity of essential oil extracted from Lippia origanoides on human gingival fibroblasts. The essential oil was obtained through hydrodistillation, and the volatile compounds were analyzed by gas chromatography mass spectrometry (GC/MS). The cytotoxicity was evaluated using an MTT assay. The cells were exposed to the essential oil for 1h at concentrations ranging from 600 μg/mL to 650 μg/mL. The major essential oil components were p-cymene (27 %), γ-terpinene (11 %), carvacrol (11.8 %), (E)-methyl cinnamate (8.3 %), α-pinene (4.6 %), thymol methyl ether (5.2 %), carvacrol methyl ether (5.2 %), (E)-nerolidol (3.9 %), and 1,8-cineole (3.5 %). The cell viabilities compared to the control group were 90.33 % (600 μg/mL), 81.17 % (610 μg/mL), and 76.04 % (620 μg/mL). The viability of cells exposed to 630 μg/mL, 640 μg/mL, and 650 μg/mL was 63.01 %, 40.88 %, and 36.15 %, respectively, which indicated an increase in cytotoxic effects as the concentration increased. Lower concentrations of L. origanoides essential oil did not result in toxic effects against gingival fibroblasts.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.